Moreover, the immunosuppressive TME, inadequate generation and function of tumor-specific CD8+ T cells, limited neoantigen availability due to impaired antigen processing and presentation, and epigenetic alterations further hinder effective immune responses (23, 24). This evidence concerns the gene CD8A and neoplasm.